Trademark: 88202257
Word
IMMKARTI
Status
Registered
Status Code
700
Status Date
Tuesday, July 2, 2019
Serial Number
88202257
Registration Number
5793130
Registration Date
Tuesday, July 2, 2019
Mark Type
4000
Filing Date
Wednesday, November 21, 2018
Published for Opposition
Tuesday, April 16, 2019

Trademark Owner History
Celgene Corporation - Original Registrant

Classifications
5 Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Trademark Events
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Aug 8, 2019
Review Of Correspondence Complete - Certificate Of Reg Mailed
Jul 2, 2019
Registered-Principal Register
Apr 16, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 16, 2019
Published For Opposition
Mar 27, 2019
Notification Of Notice Of Publication E-Mailed
Mar 12, 2019
Law Office Publication Review Completed
Mar 11, 2019
Approved For Pub - Principal Register
Mar 11, 2019
Data Modification Completed
Mar 4, 2019
Teas/Email Correspondence Entered
Mar 4, 2019
Correspondence Received In Law Office
Mar 4, 2019
Assigned To Lie
Feb 26, 2019
Teas Response To Suspension Inquiry Received
Feb 26, 2019
Notification Of Letter Of Suspension E-Mailed
Feb 26, 2019
Letter Of Suspension E-Mailed
Feb 26, 2019
Suspension Letter Written
Feb 25, 2019
Assigned To Examiner
Dec 11, 2018
New Application Office Supplied Data Entered In Tram
Nov 24, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24